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Abstract 
Maternal immune activation (MIA) is a common environmental insult on the developing brain 
and represents a risk factor for neurodevelopmental disorders. Animal models of in utero 
inflammation further revealed a causal link between maternal inflammatory activation during 
pregnancy and behavioural impairment relevant to neurodevelopmental disorders in the 
offspring. Accumulating evidence point out that proinflammatory cytokines produced both in 
the maternal and fetal compartments are responsible for social, cognitive and emotional 
behavioral deficits in the offspring.  
Polyunsaturated fatty acids (PUFAs) are essential fatty acids with potent immunomodulatory 
activities. PUFAs and their bioactive derivatives can promote or inhibit many aspects of the 
immune and inflammatory response. PUFAs of the n-3 series (‘n-3 PUFAs’, also known as 
omega-3) exhibit anti-inflammatory/pro-resolution properties and promote immune functions, 
while PUFAs of the n-6 series (‘n-6 PUFAs’ or omega-6) favor pro-inflammatory responses. 
The present study aimed at providing insight into the effects of n-3 PUFAs on the 
consequences of MIA on brain development. We hypothesized that a reduction in n-3 PUFAs 
exacerbates both maternal and fetal inflammatory responses to MIA and later-life defects in 
memory in the offspring.  
Based on a lipopolysaccharide (LPS) model of MIA (LPS injection at embryonic day 17), we 
showed that n-3 PUFA deficiency 1) alters fatty acid composition of the fetal and adult 
offspring brain; 2) exacerbates maternal and fetal inflammatory processes with no significant 
alteration of microglia phenotype, and 3) induces spatial memory deficits in the adult 
offspring. We also showed a strong negative correlation between brain content in n-3 PUFA 
and cytokine production in MIA-exposed fetuses. Overall, our study is the first to address the 
deleterious effects of n-3 PUFA deficiency on brain lipid composition, inflammation and 
  
memory performances in MIA-exposed animals and indicates that it should be considered as a 
potent environmental risk factor for the apparition of neurodevelopmental disorders. 
 
  
Introduction 
Maternal immune activation (MIA), occurring in a context of bacterial or viral infection, is a 
common environmental insult on the developing brain and represents a risk factor for 
neurodevelopmental disorders such as schizophrenia, autism or cerebral palsy (Bilbo et al., 
2018; Estes and McAllister, 2016; Fleiss and Gressens, 2012; Hagberg et al., 2015; Knuesel et 
al., 2014; Madore et al., 2016; Patterson, 2011, 2009; Van Steenwinckel et al., 2014). MIA 
has recently been associated to altered connectivity in the prefrontal cortex, temporo-parietal 
junction, and basal ganglia of neonates and toddlers, further linking prenatal inflammation to 
psychiatric risk in humans (Spann et al., 2018).  
Animal models of in utero inflammation (triggered by viral polyinosinic:polycytidylic 
[poly(I:C)] or bacterial [lipopolysaccharide, LPS] mimics) further revealed a causal link 
between maternal inflammatory activation during pregnancy, disorganized brain 
cytoarchitecture and behavioural impairment relevant to neurodevelopmental disorders in the 
offspring (Bilbo and Schwarz, 2012; Choi et al., 2016; Deverman and Patterson, 2009; Estes 
and McAllister, 2016; Fernández de Cossío et al., 2017; Hui et al., 2018; Shin Yim et al., 
2017). Accumulating evidence point out that proinflammatory cytokines produced both in the 
maternal and fetal compartments, are responsible for social, cognitive and emotional 
behavioral deficits in the offspring (Ashdown et al., 2006; Bilbo et al., 2018; Cai et al., 2000; 
Estes and McAllister, 2015; Golan et al., 2005; Hao et al., 2010; Liverman et al., 2006; 
Urakubo et al., 2001). Interleukin-1beta (IL-1β), IL-6 and Tumor Necrosis Factor alpha 
(TNFα) disrupt brain structures connectivity involved in social, emotional and memory 
processes (Baharnoori et al., 2009; Cai et al., 2000; Fatemi et al., 2009; Giovanoli et al., 2015; 
Golan et al., 2005; Graciarena et al., 2010; Lowe et al., 2008; Samuelsson et al., 2006). More 
recently, IL-17 has been shown to mediate maternal poly-IC-induced social behavior 
impairment and abnormal cortical development in offspring (Choi et al., 2016; Shin Yim et 
  
al., 2017). A particular role has been attributed to maternal and fetal IL-6 in offspring 
cognitive disorders in humans (Spann et al., 2018). Indeed, prenatal exposure to IL-6 
recapitulates the deficits in hippocampal synaptic transmission and spatial learning that are 
classically observed in adult offspring in a context of MIA (Patterson, 2009; Samuelsson et 
al., 2006). These deficits can be reversed by treating the mothers with an anti-IL-6 antibody 
(Mouihate and Mehdawi, 2016). Hence, the production of IL-6 in the pregnant mother and in 
the fetal brain is critical to MIA-induced cognitive impairment in the offspring.  
Polyunsaturated fatty acids (PUFAs) are essential fatty acids with potent immunomodulatory 
activities (Calder 2005). PUFAs and their bioactive derivatives can promote or inhibit many 
aspects of the immune and inflammatory response. Notably, PUFAs of the n-3 series (‘n-3 
PUFAs’, also known as omega-3) exhibit anti-inflammatory/pro-resolutive properties and 
promote immune functions, while PUFAs of the n-6 series (‘n-6 PUFAs’ or omega-6) favor 
pro-inflammatory responses (Calder, 2006, 2001; Layé et al., 2018; Orr et al., 2013b). As 
vertebrates lack the necessary enzymes for de novo synthesis of n-6 and n-3 PUFAs, these 
fatty acids have to be provided by the diet (Bazinet and Layé, 2014). When increased by 
dietary or genetic approaches, we and others showed that n-3 PUFAs down-regulate the 
production of proinflammatory cytokines both at the periphery and in the brain, while n-6 
PUFAs promote their synthesis and release (Delpech et al., 2015b, 2015a; Fourrier et al., 
2017; Hopperton et al., 2017, 2016; Labrousse et al., 2012; Madore et al., 2014; Mingam et 
al., 2008; Orr et al., 2013a). The central anti-inflammatory effects of n-3 PUFAs are mainly 
mediated by docosahexaenoic acid (DHA, 22:6 n-3), the main long chain (LC) n-3 PUFA 
accumulating in the brain (Bazinet and Layé, 2014; Layé et al., 2018; Orr et al., 2013b). DHA 
targets microglia, the brain resident innate immune cells to dampen the production and action 
of the proinflammatory cytokines IL-6, IL-1β and TNFα (De Smedt-Peyrusse et al., 2008; 
Fourrier et al., 2017; Inoue et al., 2017; Mancera et al., 2017; Nadjar et al., 2016; Tremblay et 
  
al., 2016). Conversely, low level of DHA in the brain enhances the production of 
proinflammatory cytokines and affects microglia phenotype and function, with a polarization 
of these cells to a pro-inflammatory phenotype (Delpech et al., 2015b; Madore et al., 2014; 
McNamara et al., 2010; Nadjar et al., 2016).  
The maternal dietary status in n-3 PUFAs is crucial for the offspring, as the embryo cannot 
produce its own DHA and therefore entirely depends on maternal supply (Gibson et al., 
1996). DHA is transferred from the mother to the offspring during gestation (blood supply) 
and lactation (milk) (Hanebutt et al., 2008; Innis, 2005; Lewis et al., 2018). Preterm infants or 
infants from mothers with dietary deficit in n-3 PUFAs have limited n-3 PUFA stores in the 
body and brain (Larque et al., 2002; Makrides et al., 1994). This might enhance the immune 
response and aggravate the cognitive deficits associated with prenatal infection. 
The present study aimed at providing insight into the effects of n-3 PUFA dietary intake 
during pregnancy and lactation on the consequences of MIA on brain development. We 
hypothesized that a reduction in maternal dietary n-3 PUFA exacerbates both maternal and 
fetal inflammatory responses to MIA and later-life defects in hippocampal connectivity and 
related memory behavior in the offspring. To this end, we evaluated developmental changes 
in offspring brain fatty acid composition as well as proinflammatory cytokine production in 
response to MIA (LPS at embryonic day 17) in a well-established dietary model of n-3 PUFA 
deficiency (Lafourcade et al., 2011; Madore et al., 2014; Mingam et al., 2008; Moranis et al., 
2012). Long-term memory and hippocampal integrity were evaluated in the adult offspring. 
Our results revealed that maternal n-3 PUFA deficiency worsens the effects of prenatal LPS 
on memory performances and brain pro-inflammatory cytokines production in the offspring. 
We also showed that IL-6 production is strongly anti-correlated to brain DHA levels, 
emphasizing the crucial role of this fatty acid in the development of later life cognitive 
abilities. 
  
 
MATERIALS AND METHODS 
 
Animals 
Animal husbandry and experimental procedures were in accordance with the EU Directive 
2010/63/EU for animal experiments and approved by the national ethical committee for care 
and use of animals (approval ID A13169). Every effort was made to minimize suffering and 
the number of animals used. All experiments were made on C57BL6/J males and females 
(Charles River, Arbresle, France). Mice were maintained under standard housing conditions 
on corncob litter in a temperature (23±1°C) and humidity (40-50%) controlled animal room 
with a 12h light/dark cycle (07h-19h) and ad libitum access to food and water. 
 
Diet and treatment 
N-6 and n-3 LC PUFAs can be biosynthesized from their dietary precursors, respectively 
linoleic acid (18:2n-6 or LA) and α-linolenic acid (18:3n-3 or ALA) (Lands et al., 1990). 
Female C57BL6/J mice were fed with isocaloric diets containing 5% fat with a high (n-3 
deficient diet) or low LA/ALA ratio (n-3 balanced diet) across gestation and lactation to 
modulate n-3/n-6 PUFAs in the offspring (Delpech et al., 2015b; Madore et al., 2014; 
Mingam et al., 2008; Moranis et al., 2012). When studied at adulthood, the male offspring 
was kept under the same diet as their dams after weaning, except for data presented in 
Figure 1B (reversal experiment in Y-maze) for which offspring were fed with n-3 PUFA 
balanced diet until weaning and then exposed to n-3 PUFA deficient diet until 
behavioral assessment.  
At G17 (17 days after mating), MIA was triggered by the intraperitoneal (i.p.) administration 
of LPS (E. Coli 0127:B8, Sigma Inc, St. Louis, MO, USA; 0.12 µg/g mouse/100 µl). The 
  
administration of the corresponding volume of saline solution (NaCl 0.9%, "Saline") was used 
as a control (Golan et al., 2005; Roumier et al., 2008).  
We generated 4 cohorts of mice in total. Cohort 1 was used to assess memory performances in 
adults (57 males from 15 dams). In cohort 2, we quantified fatty acids levels and cytokine 
production in fetuses and dams (30 dams were used, fetuses from the same litter were pooled 
for n=1). Cohort 3 was used for FACS analysis (22 dams were used, fetuses from the same 
litter were pooled for n=1). Cohort 4 was used to assess cFos expression and measure fatty 
acid composition of adult livers and brainstems (40 males from 18 dams were used).  
 
Assessment of memory performances 
Memory tests always took place in the morning (between 8:00AM and 11:00AM). 3 months 
old mice were first handled for 5 min every day for two weeks before initiation of the 
experiments. All experiments were performed in a room adjacent to the vivarium with light 
intensity at 78 Lux.  
Spatial recognition. The hippocampus-dependent spontaneous spatial recognition in the Y-
maze was used in a two-trial procedure as previously described (Delpech et al., 2015b; 
Labrousse et al., 2009; Moranis et al., 2012). A Y-shaped maze was used, where each arm 
was 34 cm long, 8 cm wide and 14 cm high. The maze floor was covered with sawdust which 
was mixed between trials in order to remove olfactory cues. Extra-maze visual cues were 
placed around the testing room and kept constant during all tests. During the first trial (trial 
1), one arm of the Y-maze was closed and mice were allowed to visit the two other arms for 5 
min. After a 30-min inter-trial interval (ITI), mice were placed back in the starting arm with 
free access to all three arms for 5 min (trial 2). We quantified the time animals spent 
exploring the novel and familiar arms during the first 3 minutes of trial 2 (Labrousse et al., 
2012). 
  
Novel object recognition. This task was used as a hippocampus-independent task (Dere et 
al., 2007) and performed as previously described (Labrousse et al., 2009). Briefly, mice were 
acclimatized to a 40x40 cm cage made of white-coated plywood with 16 cm-high walls, 15 
min per day for a week before training. As before, the maze floor was covered with sawdust 
which was mixed between trials in order to remove olfactory cues. During a first 10-min 
training period, two identical objects with a particular shape and color were presented to mice. 
After a 30-min ITI, one of the familiar objects was replaced by a novel object with a different 
shape and color, to test for memory retention. During the 5 min of testing, exploration of an 
object was defined as pointing the nose towards the object and/or touching the object with the 
nose. 
 
Immunohistochemistry 
cFos protein expression was assessed in the CA1 and dentate gyrus (DG) of the hippocampus 
of adult mice 60 min after the completion of the Y-maze task (trial 2), i.e. 90 min after 
acquisition (Labrousse et al., 2009). A decrease of this marker in the hippocampus is known 
to predict dampened neuronal activation and is associated with spatial memory impairments 
(Labrousse et al., 2012). Animals were deeply anesthetized with pentobarbital, intracardially 
perfused with Phosphate Buffer Saline (PBS, pH 7.4) for 5 min, followed by 10-min 
perfusion with 4% paraformaldehyde (PFA). Brains were removed, post-fixed in 4% PFA for 
4h at 4°C, cryoprotected in 30% sucrose for 24h, quickly frozen in liquid azote, and stored at -
80°C before sectioning. Free-floating 30µm coronal sections were collected throughout the 
hippocampus, using a cryostat. cFos immunohistochemistry was then performed as previously 
described (Labrousse et al., 2009). Briefly, rabbit polyclonal antiserum raised against cFos 
(Santa Cruz Biotechnology, Santa Cruz, CA) was diluted 1:1000 in Tris Buffer Saline (TBS) 
containing 0.3% Triton X-100, 2% donkey serum, 1% Bovine Serum Albumin (BSA), and 
  
sections were incubated overnight at room temperature (RT), before incubation for 2 h with 
biotinylated donkey anti-rabbit antibody (1:1000; Amersham Pharmacia Biotech Europe, 
Freiburg, Germany). Slices were then incubated for 2 h with avidin-biotin peroxidase 
complex (1:1000; Vectastain ABC kit, Vector laboratories, Burlingame, CA) and staining was 
revealed using diaminobenzidine and the nickel-enhanced glucose oxidase method (Shu et al., 
1988). Sections were then mounted onto gelatine-coated slides. The procedure also included 
negative controls with omission of the primary antibody, which did not show any 
immunoreactivity (data not shown). 
Brain sections were examined under a light microscope with a 10X objective (Nikon Eclipse 
E 400) and images were captured by a high-resolution digital Nikon DXM 1200 camera 
(Nikon Corporation, Champigny-sur-Marne, France). Camera aperture, magnification, light 
power, and exposure time were fixed for all images. ACT-1 software (Nikon Corporation, 
Champigny-sur-Marne, France)-generated images were stored. Image editing software 
(Adobe Photoshop, Adobe Systems, San Jose, CA) was used to adjust size, brightness, and 
contrast (same settings for all images). Quantification of cFos-immunoreactive cells was 
performed with NIH-imaging software Scion Image (Frederick, MD). The number of cFos 
positive cells was quantified from all consecutive sections containing the structure of interest, 
across both hemispheres.  
 
Quantitative Real-Time PCR  
Two µg of total RNA were reverse transcribed with Moloney Murine Leukemia Virus reverse 
transcriptase (Invitrogen, Cergy-Pontoise, France). Quantitative PCR was then performed 
using the Applied Biosystems Assay-on-Demand Gene Expression Products protocol as 
previously described (Madore et al., 2013; Rey et al., 2016). Briefly, TNFα, IL-1β, IL-6, IL-
10, IL-6 receptor (gp130), CD11b and housekeeping gene (β2-microglobulin) cDNA were 
  
amplified by PCR by using an oligonucleotide probe with a 5’ fluorescent reporter dye (6-
FAM) and a 3’ quencher dye (NFQ). Fluorescence was determined using an AB 7500 Real 
Time PCR system (Applied Biosystems, Foster city, CA) and final quantification was 
performed using the comparative threshold (Ct) method (Livak and Schmittgen, 2001). For 
each experimental sample, the difference between target and housekeeping gene Ct values 
(ΔCt) was used to normalize for difference in the amount of total nucleic acid added to each 
reaction and the efficiency of the RT step. Values were then expressed relative to the mean 
ΔCt value obtained for the balanced-saline group (calibrator ΔCt) by substracting ΔCt for 
each experimental sample from calibrator ΔCt (=ΔΔCt). The amount of target gene (linear 
value) normalized to the housekeeping gene and relative to the calibrator was determined by 
2
-ΔΔCt
 (relative fold change). Data are presented as mean relative fold change ± SEM. 
 
Cytokine assays 
Maternal blood samples and placenta were collected in EDTA-coated vials and centrifuged 
for 15min at 13000 rpm at 4°C. Proteins were extracted using a Bioplex extraction kit (Bio-
rad Laboratories, Beverly, MA). All samples were aliquoted and stored at -80°C until use. IL-
6 measurement in placenta extracts was performed by ELISA according to manufacturer's 
instructions (R&D Systems, Minneapolis, MN, USA). Cytokines were measured in the 
maternal blood by using a LINCOplex multiplex kit (IL-1, IL-6, TNF, IL-10; Millipore).  
 
Analysis of Fatty Acid Contents 
Lipids were extracted from fetal brains, placenta, adult offspring’s liver and brainstem as 
previously described (Delpech et al., 2015b, 2015b; Joffre et al., 2016; Labrousse et al., 2012; 
Lafourcade et al., 2011). Briefly, fatty acid methyl esters were analyzed on a Hewlett-Packard 
5890 series II gas chromatograph equipped with a split/splitless injector, a flame ionization 
  
detector (Palo Alto, CA, USA), and a CPSil88-silica capillary column (100m  0.25mm i.d., 
film thickness 0.20µm, Varian, Les Ulis, France). Injector and detector were maintained at 
250°C and 280°C, respectively. Hydrogen was used as a carrier gas (inlet pressure 210 kPa). 
The oven temperature was fixed at 60°C for 1min, increased to 85°C at a rate of 3°C/min and 
then to 190°C at a rate of 20°C/min and left at this temperature for 65min. Fatty acid methyl 
esters were identified by comparing with commercial standards.  
 
Isolation of microglia and FACS analyses 
Microglia were isolated from E17 brain homogenates as previously described (Delpech et al., 
2015a; Madore et al., 2013). Briefly, brains were rinsed in PBS and meninges were removed. 
Brains were the homogenized in Hanks’ Balanced Salt Solution (HBSS), pH 7.4 passing 
through a 70 µm nylon cell strainer. Homogenates were centrifuged at 600g for 6 min. 
Supernatants were removed and cell pellets were re-suspended in 70% isotonic Percoll (GE-
Healthcare, Aulnay sous Bois, France). A discontinuous Percoll density gradient was set up as 
follows: 70%, 50%, 35% and 0% isotonic Percoll. Gradients were centrifuged at 2000g for 20 
min. Microglia cells were collected at the interphase between the 70% and 50% Percoll layers 
(Frank et al., 2006; Nair et al., 2007). Cells were washed and counted with a hemacytometer. 
Microglial cells were re-suspended in Phosphate Buffer Saline solution (PBS)/0.1% Bovine 
Serum Albumin (BSA) to perform flow cytometry analysis. Microglial preparations were 
incubated with anti-CD16/CD32 antibody (eBiosciences, Paris, France) to block Fc receptors 
for 10 min on ice. Cells were washed and then incubated for 45 min with the appropriate 
conjugated antibodies: anti-CD11b-APC, anti-CD45-PerCP Cy5.5, anti-MHC-II-FITC, anti-
CD86-FITC, anti-CD130-APC, anti-TLR4-APC (eBiosciences) and anti-CD36-PE, anti-
CD206-FITC, anti-CD126-PE (Biolegend, Saint Quentin Yvelines, France) antibodies. Cells 
were washed and then suspended in PBS/BSA 0.1% for analysis. Non-specific binding was 
  
assessed by using non-specific, isotype-matched antibodies. Antigen expression was 
determined using a Becton–Dickinson LSRFortessa™ multicolor cytometer. Ten thousand 
events were recorded for each sample and isotype matched-conjugate. Data were analyzed 
using FlowJo software and gating for each antibody was determined based on non-specific 
binding of appropriate negative isotype stained controls.  
 
Statistical analyses 
All data are expressed as means ± SEM. Normality and homoscedasticity of data was assessed 
by Shapiro-Wilk test and Brown-Forsythe test respectively. Then results were analysed using 
two-way analysis of variance (ANOVA) (diet x prenatal treatment) using group as between 
factor when applicable or Kruskal-Wallis test. Significant effects were further analysed either 
with Bonferroni post-hoc test when interaction was statistically positive or with Mann-
Whitney U-test. Specific comparison between novel and familiar arms was assessed with 
paired t-tests. To analyse recognition index in the novel object recognition task, we performed 
one sample t-tests (comparison to chance level). For all results, statistical significance was set 
at p<0.05. 
We used principal component analysis (PCA) to identify cytokines and fatty acids patterns in 
E17 fetuses 3h after Saline or LPS injection. The PCA is a dimension-reduction approach that 
summarizes data into principal components (PC) that maximize the variance of the data 
considered. These PCs were uncorrelated linear combinations of the initial variables, which 
can be interpreted as “patterns”. PCA generates factor loadings that reflect the correlation of 
each variable with the PC and a principal component score for each individual that 
corresponds to a linear combination of the cytokines and fatty acids that load heavily within 
each pattern. A higher component score indicated a higher adherence to that pattern. To 
facilitate the interpretation of our patterns we have calculated the correlations between each 
  
variable and the PCs. We kept only the variables that had a correlation coefficient 
significantly different from 0. The number of components/patterns was selected according to 
their eigenvalues, each component with an eigenvalue higher than 1 was retained (Kaiser 
criteria). Statistical analyses were performed using R version 3.3.0 (FactoMineR). 
 
Results 
 
Effect of dietary manipulations and MIA on fatty acid composition in the fetus and adult 
offspring. 
Both dietary n-3 PUFAs and MIA alter fatty acid composition in the fetal brain.  
Fatty acids levels were measured in the fetal brain (Table 1) 3 h after MIA. ANOVA analyses 
revealed a significant effect of the diet. In n-3 deficient mice, n-6 species (total n-6 PUFAs 
and docosapentaenoic acid - DPA) and the n-6/n-3 PUFA ratio were increased while n-3 
PUFAs species (total n-3 PUFA and docosahexaenoic acid - DHA) were decreased (Two-way 
ANOVA, Diet effect, DPA n-6: p=0.007, DHA: p=0.03, Total n-6: p=0.008, Total n-3: 
p<0.001, n-6/n-3 ratio: p=0.003). MIA also decreased brain levels in n-3 PUFAs, especially 
DHA (Two-way ANOVA, Treatment effect, DHA: p=0.002, Total n-3: p<0.001, n-6/n-3 
ratio: p=0.008, Total PUFAs: p=0.035). There was no significant interaction between diet and 
treatment (statistics in Supplementary Table 1).  
We also analysed lipid composition of the placenta. In this tissue, n-3 PUFA deficiency 
decreased total PUFA levels (p=0.04) and increased n-6/n-3 ratio (p<0.001). In addition, we 
observed an increase in n-6 species (Two-way ANOVA, Diet effect, Total n-6: p=0.007, DPA 
n-6: p<0.001, ALA: p<0.001) and a decrease in n-3 PUFAs (Two-way ANOVA, Diet effect, 
Total n-3: p<0.001, EPA: p<0.001, DHA: p<0.001) in the placenta of n-3 PUFA deficient 
  
mice. However, no significant effect of MIA and no interaction between diet and treatment 
were revealed (statistics in Supplementary Table 2).  
These data suggest that 1) maternal dietary manipulation affected brain PUFA composition 
(both n-3 and n-6 species) very early in development; 2) MIA specifically decreased DHA 
levels in the fetal brain without altering other lipids; 3) the placenta and fetal brain were 
differentially affected by the diet and MIA.  
 
Both dietary n-3 PUFAs and MIA alter fatty acid composition in the adult offspring. 
 Fatty acid composition was then analysed in the brainstem of adult offspring. Almost all fatty 
acids species were modified by the diet (Two-way ANOVA, Diet effect, saturated fatty acid 
SFA: p=0.003, monounsaturated fatty acid MUFA: p<0.001, LA: p<0.001, dihomo-
linolenic acid DGLA: p<0.001, arachidonic acid AA: p<0.001, docosatetraenoic acid DTA 
n-6: p<0.001, DPA n-6: p<0.001, Total n-6: p<0.001, eicosapentaenoic acid EPA: p<0.001, 
DPA n-3: p<0.001, DHA: p<0.001, Total n-3: p<0.001, n-6/n-3 ratio: p<0.001, Total PUFAs: 
p<0.001). Moreover, DHA and total n-3 PUFAs were also significantly increased by MIA, 
though differences were very slight (Two-way ANOVA, Treatment effect, DHA: p=0.05, 
Total n-3 PUFAs: p=0.05) (Table 3, statistics in Supplementary Table 3). This shows that 
while MIA significantly decreased DHA levels by 29-39% in fetal brain, a slight 4% increase 
in DHA concentrations was observed in the brainstem of adult offspring. The dietary 
manipulation, however, strongly affected brain lipid composition in the long term (for all 
classes of fatty acids studies, i.e. PUFAs, MUFAs and SFAs). 
Fatty acid composition was also significantly altered by the diet in the liver of adult offspring 
(Two-way ANOVA, Diet effect, AA: p<0.001, DTA n-6: p<0.001, DPA n-6: p<0.001, Total 
n-6: p<0.001, ALA: p<0.001, EPA: p<0.001, DHA: p<0.001, Total n-3: p<0.001, n-6/n-3 
ratio: p<0.001). MIA significantly decreased SFA (p=0.011) and N-3 PUFAs (ALA: p=0.013, 
  
EPA: p=0.018, DHA: p=0.004, Total n-3: p=0.004). As revealed by the interaction between 
diet and treatment, a significant decrease of n-3 PUFAs levels was measured in n-3 balanced 
fed mice that were exposed to MIA compared to n-3 PUFA balanced mice (Bonferonni post-
hoc tests, ALA: t(11)=4.322**, EPA: t(11)=4.11*, DHA: t(11)=5.76*** and total n-3 PUFAs: 
t(11)=5.70***) (Table 4, statistics Supplementary Table 4).  
 
Altogether, lipid analyses revealed 1) a strong effect of the dietary manipulation on fetal brain 
lipid composition as early as at E17; 2) a long-term effect of the diet on brain and body lipid 
composition; 3) a strong effect of MIA on DHA levels, 3 h after LPS treatment, while the 
impact is much lighter at adulthood; 4) a differential impact of diet and MIA on brain and 
peripheral organs at adulthood. 
 
Effect of n-3 PUFA deficiency on memory performances in MIA-exposed animals. 
N-3 PUFA deficiency reveals spatial memory deficits in MIA-exposed adult mice. 
Both MIA and n-3 PUFA deficiency have been shown to influence memory performances 
(Golan et al., 2005; Janssen et al., 2015). We thus evaluated spatial memory in adult offspring 
using a Y-Maze task (Labrousse et al., 2009). While balanced-LPS mice spent significantly 
more time exploring the novel arm, MIA-exposed mice fed with n-3 deficient diet (Deficient-
LPS) failed to discriminate the novel arm from the familiar one (Figure 1A) (Paired t-tests; 
Deficient-LPS: t(12)=0.069, p=0.94; Balanced-LPS: t(6) =2.655, p=0.037). Both deficient-
saline and balanced-saline groups spent significantly more time in the novel arm than in the 
familiar one (Paired t-tests; Deficient-saline: t(7)=3.206, p=0.014; Balanced-saline: t(6) 
=4.892, p=0.002). 
 
  
The perinatal period is a critical window to reveal the deleterious effects of n-3 PUFA 
deficiency in MIA exposed animals. 
We further examined whether the deleterious effects of n-3 PUFA deficiency on spatial 
memory abilities mainly relied on their brain accretion during development or both on brain 
accretion during development and turnover at adulthood. Animals were thus fed with n-3 
PUFA balanced diet until weaning and then exposed them to n-3 PUFA deficient diet until 
behavioral assessment. All animals spent more time in the novel arm than in the familiar one 
(Figure 1B) (Paired t-tests; Balanced-saline: t(10) =13.16, p<0.001; Balanced-LPS: t(8)=4.04, 
p=0.0037; Balanced/Deficient-saline: n=14,t(13)=5.557, p<0.001; Balanced/Deficient-LPS: 
n=8, t(7) =2.956, p=0.02).  
 
N-3 PUFA deficiency does not affect recognition memory in MIA-exposed adult mice. 
We then assessed recognition memory using Novel Object Recognition (NOR). LPS-treated 
mice failed to discriminate the novel object regardless of the diet while saline-treated animals 
spent significantly more time exploring the new object than the familiar one (Figure 1C) 
(One-Sample t-tests; Deficient-saline: t(8)=6.099, p=0.0003; Deficient-LPS: t(13)=0.1115, 
p=0.91; Balanced-saline: t(7) =5.95, p=0.0006; Balanced-LPS: t(6) =0.5949, p=0.5926).  
 
Dietary n-3 PUFAs deficiency reveals MIA-induced decrease in cFos expression in the 
dentate gyrus (DG). 
We then investigated cFos expression, as a marker of neuronal activation, 60 min after trial 2 
of the Y-Maze task (Figure 2). In the CA1 region of the hippocampus, the number of cFos-
positive cells was significantly decreased in MIA-exposed mice as compared to saline-treated 
animals, in both diet groups. However, this decrease was greater in n-3 deficient mice treated 
with LPS when compared to n-3 balanced animals exposed to MIA. The number of cFos-
  
positive cells was not significantly modified by MIA in the DG of n-3 PUFAs balanced fed 
mice, n-3 PUFA deficiency revealed MIA-induced cFos expression decrease (CA1: Kruskal-
Wallis test: K(4,24)=17.84, p=0.0005, Mann-Whitney comparisons: Deficient Saline vs 
Deficient LPS p=0.002 ; Balanced Saline vs Balanced LPS p=0.002 ; Deficient LPS vs 
Balanced LPS p=0.03 . DG: Kruskal-Wallis test: K(4,24)=11.85, p=0.008, Mann-Whitney 
comparisons: Deficient Saline vs Deficient LPS p=0.009 ; Balanced Saline vs Balanced LPS 
p=0.30 ; Deficient LPS vs Balanced LPS p=0.009).  
 
N-3 PUFA deficiency exacerbates MIA-induced cytokine production in both maternal 
and fetal compartments.  
Numerous studies have shown that the effects of MIA on the developing brain are mediated 
mostly by the indirect production of pro-inflammatory cytokines such as IL-6, in both 
maternal and fetal compartments (Ashdown et al., 2006; Bilbo and Schwarz, 2012; Mouihate 
and Mehdawi, 2016). We thus assessed the impact of n-3 PUFAs on maternal cytokine 
expression in response to MIA using bioplex assay. The levels of pro-inflammatory cytokines 
IL-1β, IL-6, TNFα, and anti-inflammatory cytokine IL-10 were measured in maternal blood 
samples 3 h after MIA (Figure 3A). Prenatal exposure to LPS significantly increased the 
protein expression of IL-6, TNFα, IL-1β and IL-10. Moreover, n-3 PUFA deficiency 
exacerbated MIA-induced IL-6 and TNFα production in maternal blood (Figure 3A) (Mann-
Whitney comparisons: IL-6: Deficient Saline vs Deficient LPS p<0.001; Balanced Saline vs 
Balanced LPS p<0.001; Deficient LPS vs Balanced LPS p<0.001; IL-1β: Deficient Saline vs 
Deficient LPS p=0.005; TNF-α: Deficient Saline vs Deficient LPS p<0.001; Balanced Saline 
vs Balanced LPS p=0.002; Deficient LPS vs Balanced LPS p=0.002; IL-10: Deficient Saline 
vs Deficient LPS p<0.001; Balanced Saline vs Balanced LPS p<0.001).  
  
In the placenta, MIA-induced IL-6 production was also exacerbated in n-3 PUFAs deficient 
mice (Mann-Whitney comparisons: Deficient Saline vs Deficient LPS p<0.001; Balanced 
Saline vs Balanced LPS p<0.001; Deficient LPS vs Balanced LPS p<0.001). 
Finally, fetal brain cytokines were measured by RTqPCR (Figure 3C). MIA significantly 
increased mRNA expression of IL-6 and this was exacerbated in n-3 PUFA deficient mice. 
The expression of other pro-inflammatory markers such as IL-1β, TNF-α, IL-6 receptor and 
CD11b was not significantly affected by the diet or MIA (Mann-Whitney comparisons: IL-6, 
Deficient Saline vs Deficient LPS p=0.002; Balanced Saline vs Balanced LPS p=0.004; 
Deficient LPS vs Balanced LPS p=0.009). 
 
Neither n-3 PUFA deficiency nor MIA modulate microglia phenotype. 
We already showed that n-3 PUFA deficiency modulates microglia phenotype, exacerbating 
their reactivity to LPS (Delpech et al., 2015a). To assess the phenotype of microglia, we 
measured the surface expression of various receptors on isolated microglia from fetuses, 3 h 
after LPS or saline injection. Flow cytometry data showed that microglial phenotype was not 
altered neither by the MIA nor by the diet in pup brain at E17 (Figure 4A). Because the 
expression of IL-6 mRNA was significantly increased in the fetal brain 3 h post-LPS, we also 
measured the expression of IL-6 receptor (CD126/CD130 subunits) protein at the surface of 
microglia and could not find any difference between groups (Figure 4B).  
 
Specific association between n-3 LC-PUFA and pro-inflammatory cytokines.  
We further assessed correlations between fatty acid profile and cytokine expression within the 
fetal brain. For each brain, we quantified both cytokine mRNAs and fatty acids, enabling us to 
seek patterns of expression of these factors within the population using principal component 
analysis (PCA). PCA showed a marked separation of all variables according to 3 main 
  
patterns (Kaiser criteria) (Figure 5A). The table represents all variables that allow defining 
each pattern. Values correspond to the correlation coefficient between each variable and the 
pattern they are part and give the weight of each factor in defining the pattern. Figure 5B is a 
schematic representation of the correlation between variables within each pattern. The length 
of each arrows is proportional to the weight of the corresponding factor in defining the 
pattern. Two arrows with opposite directions means that variables are anti-correlated. The 
first pattern (“pattern 1”, defined by 9 variables among all variables measured) explained 
49.28% of the total variance within the population and revealed an anti-correlation between 
IL-6, n-6/n-3 ratio, AA/DHA ratio on one hand and DHA, n-3 PUFAs, DHA/DPA on the 
other hand (Figure 5B). Pattern 2 explained 25.22% of the total variance within the 
population. It revealed a positive score for AA, DTA, DPA and n-6 PUFAs suggesting that 
fetuses can be classified according to their n-6 PUFAs levels as well. The third component 
(“Pattern 3”) explained 15.93% of the total variance within the population. It revealed a 
positive score for pro-inflammatory cytokines and a negative score for EPA.  
Overall, PCA reported negative relationship between long-chain n-3 PUFAs levels and pro-
inflammatory cytokines expression within the fetal brain, DHA levels being more negatively 
correlated to IL-6 expression while EPA content was negatively correlated to TNFα and IL-1β 
production.  
 
Discussion 
Only few studies have assessed the impact of n-3 PUFAs on the behavioral and molecular 
consequences of MIA (Delattre et al., 2017; Li et al., 2015; Weiser et al., 2015). These reports 
showed the protective effect of DHA supplementation on cognitive, emotional and social 
behaviors in animals treated with LPS (Delattre et al., 2017) or polyI:C (Li et al., 2015; 
Weiser et al., 2015) during prenatal period. Yet, this study is the first to address the 
  
deleterious effects of n-3 PUFA deficiency on brain lipid composition, inflammation, 
microglial phenotype and memory performances in the offspring. We here demonstrated that 
maternal dietary n-3 PUFA deficiency 1) alters fatty acid composition of the fetal and adult 
offspring brain; 2) exacerbates maternal and fetal inflammatory processes with no significant 
alteration of microglia phenotype, and 3) induces spatial memory deficits in the adult 
offspring. We also showed a strong negative correlation between brain content in LC n-3 
PUFA and cytokine production in MIA-exposed fetuses.  
 
Both n-3 PUFAs and MIA alter fatty acid composition in the brain of the offspring.  
The developing brain expresses the enzymatic machinery to convert precursors of PUFAs into 
long chains such as DHA and AA (Green and Yavin, 1996). PUFAs start accumulating in 
rodents very early during fetal life, yet it accelerates dramatically around gestational day 17 
(Clandinin, 1999; Cunnane and Chen, 1992; Green and Yavin, 1996; Kuipers et al., 2012; 
Sinclair and Crawford, 1972). We measured fetal brain fatty acid composition as early as at 
E17 and showed for the first time that maternal dietary exposure to n-3 PUFA deficient diet 
from E0 to E17 was sufficient to significantly affect offspring’s brain lipid composition. 
Notably, these effects were still visible in adult offspring, suggesting that no compensatory 
mechanisms were put in place later on.  
MIA altered brain fatty acid composition in fetus brain as soon as 3 hours post-LPS injection, 
in both dietary groups, while no modification was seen in the placenta. DHA concentration 
was significantly decreased in MIA-exposed mice. As a plausible explanation, PUFAs can be 
unesterified from the membrane and converted into bioactive mediators (Orr et al., 2013a; 
Serhan, 2017). EPA and DHA derivatives display potent anti-inflammatory and pro-resolutive 
activities (Layé et al., 2018; Serhan, 2017). Resolvin D1 and E1 derived respectively from 
DHA and EPA exert potent anti-inflammatory properties pushing microglia toward a pro-
  
resolution phenotype (Bisicchia et al., 2018; Harrison et al., 2015; Kantarci et al., 2018; Li et 
al., 2014; Rey et al., 2016; Xu et al., 2013; Zhu et al., 2016). MIA-induced fetal brain 
inflammation is likely to promote cleavage of DHA out of plasma membranes and conversion 
into lipid mediators as part of the local inflammatory response (Calder, 2017). Hence, this 
would lead to decrease in total DHA content in offspring’s brain, as observed here.  
 
N-3 PUFA deficiency induces memory deficits in MIA-exposed adult offspring. 
We showed that systemic maternal inflammation produces long-term behavioral deficits in n-
3 PUFA deficient adult offspring. Animals could not differentiate the novel arm from the 
familiar one in the Y-maze task, as a surrogate of deficits in spatial memory. This suggests 
that low brain n-3 PUFA content is correlated to poor cognitive abilities and that it may 
represent a risk factor for neurodevelopmental disorders (Madore et al., 2016). This also 
echoes many studies indicating that hippocampal n-3 PUFA levels modulate cognitive 
performances (Joffre et al., 2014). We and others have previously shown that increased brain 
content of DPA n-6, together with reduced brain DHA content, is associated with behavioral 
impairment in adult rodents fed with diet deprived of n-3 PUFAs (Lafourcade et al., 2011; 
Larrieu et al., 2012, 2014; Lim et al., 2005; Mingam et al., 2008).  
Surprisingly, we also found that when fed a n-3 balanced diet, LPS-treated animals were able 
to discriminate the novel arm from the familiar one, suggesting that MIA did not impact their 
spatial memory. This is in contradiction with previous reports showing behavioral deficits in 
mice exposed to LPS at E17, such as memory impairment in the Morris water maze task 
(Golan et al., 2005), anxiety and depressive-like symptoms (in the elevated plus maze and 
forced swimming test, (Enayati et al., 2012)) or amphetamine-induced hyper-locomotion 
(Zager et al., 2012). Moreover, other studies using different MIA models (intraperitoneal 
injection of polyI:C, mimicking viral infection, or different time of LPS injection) showed 
  
protective effects of n-3 PUFAs on social interaction and dopaminergic system function 
(Delattre et al., 2017; Fortunato et al., 2017). In all these studies, mice were fed with standard 
chow, while we fed control mice with n-3 PUFA balanced diet. We previously showed that 
fatty acid composition is different between standard chow (A04) and n-3 PUFA balanced diet 
(Joffre et al., 2016). Specifically, the n-6/n-3 PUFA ratio is higher in the standard diet as 
compared to the n-3 PUFA balanced diet, leading to differences in brain fatty acid 
composition, which might explain the discrepancies in behavioral outcome (Joffre et al., 
2016). Moreover, dose/source of LPS and mouse strains vary in all these studies, which might 
also account for differential effects on behavior (Enayati et al., 2012; Golan et al., 2005; 
Zager et al., 2012). Enayati et al., for instance, had a closer look to the dose effect of prenatal 
LPS on anxiety and mood disorders and showed that the behavioral alterations were highly 
dependent on the dose of endotoxin injected to the mother (ranging from 50 to 500 mg/kg 
LPS; (Enayati et al., 2012)).  
Overall, our data show for the first time that n-3 PUFA deficiency is a risk factor for the 
development of cognitive impairment in the context of MIA. This is in line with clinical data 
showing that n-3 PUFAs deficiency increases the risk of developing ADHD, autism or 
schizophrenia (Al-Farsi et al., 2013; Brigandi et al., 2015; Crippa et al., 2016; Hoen et al., 
2013; Jory, 2015; Kirby et al., 2010; Mostafa et al., 2015; Parletta et al., 2016; Pawelczyk et 
al., 2015; Solberg et al., 2016; van der Kemp et al., 2012; Vancassel et al., 2001; Wiest et al., 
2009). Conversely, interventional studies supplemented mothers and/or infants with n-3 
PUFAs over the perinatal period with mixed results (Amminger et al., 2015, 2007; Bent et al., 
2011; Cooper et al., 2016; Dubnov-Raz et al., 2014; Gillies et al., 2012; Gould et al., 2014; 
Huss et al., 2010; Jiao et al., 2014; Mankad et al., 2015; McGorry et al., 2017; Meguid et al., 
2008; Ooi et al., 2015; Politi et al., 2008). Hence, we need more preclinical studies to better 
  
characterized the type of n-3 PUFAs required (precursors vs EPA alone or in combination 
with DHA), duration and time-window of the supplementation. 
 
Structure-dependent effects of n-3 PUFA deficiency on MIA-exposed mice. 
In addition to the Y-maze task, we also tested cognitive abilities of the offspring in the novel 
object recognition task. The spatial memory test (Y-maze) is considered as hippocampus-
dependent (Dellu et al., 2000) whereas the novel object recognition test is cortex-dependent 
and hippocampus-independent (Dere et al., 2007). Our data showed that n-3 PUFA deficiency 
revealed memory deficits in the Y-maze while it did not in the novel object recognition task, 
as n-3 PUFA balanced mice were already impaired. These results suggest a specificity of 
action of n-3 PUFAs on fetal hippocampus. Our group and others previously showed that 
PUFA accretion is region-dependent in adults (Carrie et al., 2000; Joffre et al., 2016). We 
found that the hippocampus was specifically enriched in PUFAs when compared to cortical 
regions (Joffre et al., 2016). This might explain why our dietary manipulations more greatly 
affect hippocampus-dependent behavior. More studies are required to understand why 
hippocampus is more sensitive to dietary n-3 PUFA intake and what are the cellular and 
molecular consequences in that region.  
 
N-3 PUFA deficiency exacerbates maternal and fetal cytokine production but does not 
affect microglia phenotype. 
We showed that n-3 PUFA deficiency exacerbates MIA-induced pro-inflammatory cytokine, 
more specifically IL-6, production in maternal plasma, placenta and fetal brain. Our data are 
in accordance with an extensive literature showing increased levels of cytokines (including 
IL-6) in embryonic serum and brain after MIA (Ashdown et al., 2006; Beloosesky et al., 
2006; Fidel et al., 1994; Gayle et al., 2004; Gilmore et al., 2005; Meyer, 2006; Paintlia et al., 
  
2004; Urakubo et al., 2001). Clinical studies showed that giving n-3 PUFA could alleviates 
perinatal inflammatory processes associated with various pathologies such as ASD, 
ADHD or perinatal depression (Chang et al., 2018a, 2018b; Madore et al., 2016; Su et 
al., 2008). Yet, our study is the first to report the aggravating action of maternal n-3 PUFA 
deficiency on inflammation, specifically on IL-6 release in both maternal and fetal 
compartment. Many studies already showed the anti-inflammatory action of n-3 PUFAs both 
in vitro on microglial cell cultures and in vivo on various pathological models but none ever 
addressed the (for extensive review, (Layé et al., 2018)). However, we are the first to 
demonstrate the exacerbating action of n-3 PUFA deficiency on inflammation in a model of 
MIA. This complete previous studies from our group showing that mice developed under a n-
3 PUFA deficient diet express higher levels of IL-1β and IL-6 mRNA in the hippocampus at 
post-natal day 21 (Madore et al., 2014). Of note, we previously demonstrated that feeding 
animals with n-3 PUFA deficient diet starting at weaning was not sufficient to increase 
cytokine production in the hippocampus of adult control animals while it only affected their 
ability to mount an inflammatory response after acute intraperitoneal LPS injection (Delpech 
et al., 2015b). This highlights the perinatal period as a critical window for n-3 PUFA 
deficiency to increase basal inflammatory processes and suggests that the developmental 
PUFA accretion phase is decisive for later cellular and behavioral activities while n-3 PUFA 
deficiency later in life has less drastic consequences. We here confirmed this assumption by 
feeding animals with n-3 PUFA deficient diet only after weaning and could not show any 
deleterious effect of the diet on cognitive abilities in the Y-maze task. This emphasizes the 
need for nutritional recommendations for pregnant and lactating women (Huffman et al., 
2011; Kim et al., 2017). 
 
  
Since n-3 PUFAs can regulate microglial function (for review, (Layé et al., 2018; Nadjar et 
al., 2016)), we also assessed microglial phenotype in all experimental groups. Indeed, these 
cells are highly versatile and can acquire diverse phenotypes, characterized by distinctive 
surface receptors expression profile, and associated with various functions including 
inflammatory or anti-inflammatory cytokine production (Garden and Möller, 2006; Madore et 
al., 2014). We could not find any effect neither of diet nor of treatment on microglial 
phenotype, suggesting that n-3 PUFA-mediated anti-inflammatory effects are not due to 
alteration of microglial status. This confirms our previous results showing that microglial 
phenotype is not affected 2 hours after peripheral injection of LPS to adult mice (Madore et 
al., 2013). Yet, one cannot exclude that fetal microglia differently responded to inflammation 
in our model. More studies are needed to further characterize the combined impact of n-3 
PUFAs and maternal immune activation on microglial function, especially on its role on 
neuronal development and maturation ((Paolicelli et al., 2011; Schafer et al., 2012; Tremblay 
et al., 2010; Zhan et al., 2014) for review, (Bilimoria and Stevens, 2015; Frost and Schafer, 
2016; Mosser et al., 2017)). 
 
PCA analysis revealed a strong negative correlation between DHA content and IL-6 
expression in the fetal brain, while EPA levels were inversely correlated to TNFα and IL-1β 
expression. Hence, the increase in IL-6 expression is likely to be due to decreased DHA 
concentration in the fetal brain. Even though more studies are required to better understand 
the molecular link between DHA levels and IL-6 expression, our observations confirmed a 
previous report in which we found that a single in vivo administration of a highly stable form 
of DHA specifically reduced LPS-induced IL-6 mRNA synthesis in the hippocampus but not 
in the hypothalamus. This was correlated to the downregulation of the IL-6 receptor subunit 
gp130 and an inhibition of IL-6-induced nuclear translocation of STAT3 in vitro (Fourrier et 
  
al., 2017). This corroborates our observations that 1) DHA levels and IL-6 production are 
anti-correlated; 2) that DHA affects brain function in a region-specific manner. Moreover, 
recent clinical data from a randomized control trial revealed a negative correlation between 
DHA and IL-6 blood levels in mothers supplemented with n-3 PUFAs during pregnancy and 
lactation (Rodriguez-Santana et al., 2017). 
 
N-3 PUFA deficiency exacerbates cytokine production as a potential mechanism 
supporting memory deficits  
Proinflammatory cytokines, such as IL-1β, TNFα and IL-6, have been directly linked to 
modulation of memory abilities in various animals models (Delpech et al., 2015b; Yirmiya 
and Goshen, 2011). Moreover, IL-6 is considered as a key player in MIA-induced behavioral 
abnormalities, corroborating our observations (Dammann and Leviton, 1997; Gilmore et al., 
2004; Samuelsson et al., 2006; Smith et al., 2007). Samuelsson and colleagues reported that 
prenatal exposure to IL-6 induces neuronal loss in the hilus, leading to hippocampal cognitive 
impairment in adulthood (Samuelsson et al., 2006). As an alternative explanation, we cannot 
exclude that n-3 PUFA deficiency directly affects neuronal development and maturation. 
Previous reports showed that DHA regulates neurogenesis, synaptogenesis, myelinogenesis 
and neuronal outgrowth (for extensive review, see (Joffre et al., 2014; Luchtman and Song, 
2013)). For instance, application of DHA on neuronal cultures increases the number of 
neurons with more mature morphology (Calderon and Kim, 2004) and increases the number 
of synapses (Cao et al., 2009; Kim et al., 2011). In vivo, n-3 PUFA supplementation increases 
the number of neurons in the cortex and hippocampus (Coti Bertrand et al., 2006), favors 
neurite growth (Calderon and Kim, 2004; Cao et al., 2009), promotes long term synaptic 
plasticity (Cao et al., 2009) and increases myelin-specific protein expression (Salvati et al., 
2008). We thus need to further decipher the relative weight of pro-inflammatory processes 
  
and direct action of lipids on neurons in the deleterious effects of n-3 PUFA deficiency on 
cognition.  
 
Overall, our study is the first to address the deleterious effects of n-3 PUFA deficiency on 
brain lipid composition, inflammation and memory performances in MIA-exposed animals 
and indicates that it should be considered as a potent environmental risk factor for the 
apparition of neurodevelopmental disorders. 
  
Fig 1: Dietary n-3 PUFA deficiency reveals spatial memory deficits in MIA-exposed 
adult mice. A. Graphical representation of the time spent (in second) in the novel or the 
familiar arm after a 30-min inter-trial interval (Y-maze task). N-3 PUFA deficiency reveals 
spatial memory deficits in MIA-exposed adult offspring (Balanced-Saline n=7; Balanced-LPS 
n=7; Deficient-Saline n=8; Deficient-LPS n=13). B. N-3 PUFA deficiency during the 
perinatal period is necessary to induce spatial memory deficits in the Y-maze task in MIA-
exposed adult offspring (Balanced-Saline n=7; Balanced-LPS n=7; Balanced/Deficient-Saline 
n=14; Balanced/Deficient-LPS n=8). C. Graphical representation of the time spent (in second) 
interacting with the novel object after a 30-min inter-trial interval in the novel object 
recognition task. N-3 PUFA deficiency does not worsen MIA-induced memory deficits in this 
test (Balanced-Saline n=8; Balanced-LPS n=7; Deficient-Saline n=9; Deficient-LPS group 
n=14). 
 
Fig 2: Dietary n-3 PUFAs deficiency reveals MIA-induced decrease in cFos expression in 
the dentate gyrus (DG). A. Quantification of cFos immunoreactivity in the CA1 region of 
the hippocampus. MIA-exposed animals showed a significant decrease in cFos 
immunoreactivity in both diet groups, yet, n-3 PUFA deficient mice displayed a greater 
inhibition. MIA-induced decrease in neuronal activation in the CA1 region of the 
hippocampus (n=6/group). B. Quantification of cFos immunoreactivity in the DG region of 
the hippocampus. N-3 PUFA deficiency induces MIA-mediated reduction in neuronal 
activation in the DG region of the hippocampus (n=6/group).  
 
Fig 3: N-3 PUFA deficiency exacerbates MIA-induced cytokine production in both 
maternal and fetal compartments. Quantification of cytokine protein expression in maternal 
plasma (n=6-11 per group) (A) and in placenta (n=6-9 per group) (B) 3 hours after LPS 
  
injection at G17. C. Quantification of cytokine mRNA expression in fetal brain 3 hours after 
LPS injection at E17 (n=6 per group). N-3 PUFA deficiency enhances MIA-induced cytokine 
production in all tissues studied. 
 
Fig 4: Neither n-3 PUFA deficiency nor MIA modulate microglia phenotype 3 hours 
after LPS injection at E17. A. FACS analysis of some microglial surface markers expression 
level, 3 hours after LPS injection. Fetal brain microglial cells were gated using CD11b
high
 and 
CD45
low
 (n=3-7/group). B. FACS analysis of IL-6 receptor subunits expression level on 
microglia, 3 hours after LPS injection. Fetal brain microglial cells were gated using CD11b
high
 
and CD45
low
 (n=3-7/group). 
 
Fig 5: Specific association between n-3 LC-PUFA and pro-inflammatory cytokines. A. 
Separation of all variables according to 3 main patterns (Kaiser criteria). The table represents 
all variables that allow defining each pattern. Values correspond to the correlation coefficient 
between each variable and the pattern they are part and give the weight of each factor in 
defining the pattern. B. Schematic representation of the correlation between variables within 
each pattern. The length of each arrows is proportional to the weight of the corresponding 
factor in defining the pattern. Two arrows with opposite directions means that variables are 
anti-correlated. The first three principal axes (patterns 1 to 3) explained 90.4 % of the 
variance. Each color represent a group of variables: blue: n-3 PUFAs, orange: n-6 PUFAs and 
n-6/n-3 ratio, green: classes of fatty acids, red: pro-inflammatory cytokines.  
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Table 1: Total fatty acid composition of fetal brain 
 
 n-3 balanced n-3 deficient Statistical effects 
Fatty acids Saline LPS Saline LPS LPS Diet LPS x Diet 
Saturated (SFA) 45.2±1.46 44.6±0.38 43.9±0.60 43.31±1.12 NS <0.05 NS 
        
Monounsaturated 
(MUFA) 
26.4±1.55 28.3±1.15 27.1±1.2 29.4±2.93 NS NS NS 
 
Polyunsaturated 
(PUFA) 
 
 
22.7±0.79 
 
21.1±1.14 
 
23.1±1.16 
 
21.1±2.18 
 
<0.05 
 
NS 
 
NS 
18:2 n-6 (LA) 2.2±0.42 2.8±0.54 2.26±0.12 2.7±0.63 NS NS NS 
18:3 n-6 (GLA) 0.05±0.01 0.06±0.01 0.06±0.01 0.09±0.05 NS NS NS 
20:2 n-6 (EDA) 0.11±0.02 0.10±0.01 0.16±0.08 0.16±0.06 NS <0.05 NS 
20:3 n-6 (DGLA) 0.33±0.05 0.34±0.04 0.37±0.07 0.42±0.13 NS NS NS 
20:4 n-6 (AA) 10.0±0.46 10.0±0.93 11.0±0.47 10.2±1.03 NS NS NS 
22:4 n-6 (DTA) 2.2±0.18 2.1±0.31 2.6±0.28 2.2±0.27 NS NS NS 
22:5 n-6 (DPA) 0.8±0.13 1.4±0.86 2.3±0.29 2.0±0.76 NS <0.01 NS 
Total n-6 
 
15.7±0.90 16.9±1.63 18.7±0.82 17.8±1.26 NS <0.01 NS 
18:3 n-3 (ALA) 
20:5 n-3 (EPA) 
0.04±0.01 
0.08±0.02 
0.04±0.02 
0.05±0.04 
0.03±0.01 
0.05±0.03 
0.05±0.04 
0.05±0.04 
NS 
NS 
NS 
NS 
NS 
NS 
22:5 n-3 (DPA) 0.23±0.03 0.14±0.10 0.08±0.01 0.12±0.07 NS <0.05 NS 
22:6 n-3 (DHA) 6.7±1.10 4.1±0.67 4.2±0.37 3.0±1.07 <0.01 <0.01 NS 
Total n-3 7.0±1.05 4.4±0.78 4.5±0.45 3.3±0.93 <0.001 <0.001 NS 
        
n-6/n-3 2.3±0.39 4.0±1.14 4.1±0.47 5.8±1.33 <0.01 <0.001 NS 
        
n = 3-4 in all groups.  
SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty 
acid; LA, Linoleic acid; GLA, gamma-linolenic acid; DGLA, di-homo-gamma-linolenic acid; 
EDA, eicosadienoic acid; AA, arachidonic acid; DTA, docosatetraenoic acid; DPA, 
Docosapentaenoic acid (n-6 and n-3); ALA, α-linolenic acid; EPA, Eicosapentaenoic acid; 
DHA, docosahexaenoic acid. 
 
  
Table 2: Total fatty acid composition of placenta 
 
 n-3 balanced n-3 deficient Statistical effects 
Fatty acids Saline LPS Saline LPS LPS Diet LPS x diet 
SFA 40.0±1.20 40.6±1.13 40.7±2.48 40.9±2.92 NS NS NS 
MUFA 16.9±1.25 18.7±0.53 19.5±4.21 19.8±2.19 NS NS NS 
PUFA 37.05±0.77 35.96±1.11 35.6±3.13 33.4±2.32 NS <0.05 NS 
        
18:2 n-6 (LA) 6.4±0.37 6.0±0.16 5.8±0.16 6.5±0.92 NS NS NS 
18:3 n-6 (GLA) 0.11±0.01 0.10±0.02 0.11±0.03 0.10±0.01 NS NS NS 
20:2 n-6 (EDA) 0.48±0.05 0.43±0.10 0.37±0.08 0.51±0.14 NS NS NS 
20:3 n-6 (DGLA) 1.36±0.06 1.23±0.06 1.14±0.09 1.13±0.14 NS <0.01 NS 
20:4 n-6 (AA) 16.2±0.76 15.5±1.21 17.1±1.81 15.2±1.25 NS NS NS 
22:4 n-6 (DTA) 2.3±0.12 2.4±0.42 2.6±0.49 2.6±0.44 NS NS NS 
22:5 n-6 (DPA) 0.9±0.12 1.0±0.12 3.6±0.21 3.0±0.67 NS <0.001 NS 
Total n-6 27.7±0.47 27.0±1.48 30.8±2.33 29.1±1.55 NS <0.01 NS 
        
18:3 n-3 (ALA) 0.12±0.02 0.14±0.03 0.03±0.03 0.04±0.01 NS <0.001 NS 
20:5 n-3 (EPA) 0.12±0.02 0.14±0.03 0.04±0.02 0.07±0.03 NS <0.001 NS 
22:5 n-3 (DPA) 0.64±0.04 0.61±0.08 0.16±0.03 0.20±0.05 NS <0.001 NS 
22:6 n-3 (DHA) 8.3±0.33 8.0±0.33 4.61±0.76 4.1±0.74 NS <0.001 NS 
Total n-3 9.4±0.32 9.0±0.42 4.83±0.81 4.4±0.79 NS <0.001 NS 
        
n-6/n-3 3.0±0.06 3.0±0.30 5.6±1.72 6.8±1.00 NS <0.001 NS 
        
n = 3-4 in all groups.  
SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty 
acid; LA, Linoleic acid; GLA, gamma-linolenic acid; DGLA, di-homo-gamma-linolenic acid; 
EDA, eicosadienoic acid; AA, arachidonic acid; DTA, docosatetraenoic acid; DPA, 
Docosapentaenoic acid (n-6 and n-3); ALA, α-linolenic acid; EPA, Eicosapentaenoic acid; 
DHA, docosahexaenoic acid. 
  
Table 3: Total fatty acid composition of adult brainstem 
 
 n-3 balanced n-3 deficient Statistical effects 
Fatty acids Saline LPS Saline LPS LPS Diet LPS x Diet 
SFA 36.9±0.40 38.0±0.30 38.5±0.30 38.8±1.0 <0.05 <0.01 NS 
MUFA 28.7±0.52
b 27.4±0.52b 25.8±0.11a 26.1±0.88a NS <0.001 <0.05 
PUFA 24.0±0.45 24.9±0.66 26.2±0.63 26.0±0.61 NS <0.001 NS 
        
18:2 n-6 (LA) 0.45±0.01 0.4±0.03 0.38±0.03 0.4±0.02 NS <0.001 NS 
20:2 n-6 (EDA) 0.15±0.01 0.14±0.01 0.14±0.01 0.14±0.02 NS NS NS 
20:3 n-6 (DGLA) 0.44±0.02 0.43±0.02 0.27±0.01 0.27±0.01 NS <0.001 NS 
20:4 n-6 (AA) 6.9±0.21 7.3±0.23 8.68±0.22 8.6±0.53 NS <0.001 NS 
22:4 n-6 (DTA) 2.1±0.03 2.1±0.07 2.93±0.04 2.9±0.02 NS <0.001 NS 
22:5 n-6 (DPA) 0.2±0.03 0.2±0.03 4.35±0.72 3.7±0.34 NS <0.001 NS 
Total n-6 10.2±0.25 10.6±0.32 16.8±0.75 16.1±0.78 NS <0.001 NS 
        
20:5 n-3 (EPA) 0.05±0.01 0.05±0 0.01±0 0.01±0 NS <0.001 NS 
22:5 n-3 (DPA) 0.17±0 0.17±0.01 0.04±0.01 0.04±0.01 NS <0.001 NS 
22:6 n-3 (DHA) 12.15±0.30 12.67±0.3 8.13±0.72 8.48±0.19 <0.05 <0.001 NS 
Total n-3 12.37±0.30 12.89±0.3 8.18±0.72 8.53±0.19 <0.05 <0.001 NS 
        
n-6/n-3 0.83±0.00 0.8±0.01 2.0±0.30 1.9±0.13 NS <0.001 NS 
        
n = 3-4 in all groups.  
SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty 
acid; LA, Linoleic acid; GLA, gamma-linolenic acid; DGLA, di-homo-gamma-linolenic acid; 
EDA, eicosadienoic acid; AA, arachidonic acid; DTA, docosatetraenoic acid; DPA, 
Docosapentaenoic acid (n-6 and n-3); ALA, α-linolenic acid; EPA, Eicosapentaenoic acid; 
DHA, docosahexaenoic acid. 18:3 n-6 (GLA, gamma-linolenic acid) and 18:3 n-3 (ALA, α-
linolenic acid): non-detectable.  
  
Table 4: Total fatty acid composition of adult liver 
 
n = 3-4 in all groups. Differences in Bonferroni post-hoc comparisons were represented with 
letters 
a,b
. 
SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty 
acid; LA, Linoleic acid; GLA, gamma-linolenic acid; DGLA, di-homo-gamma-linolenic acid; 
EDA, eicosadienoic acid; AA, arachidonic acid; DTA, docosatetraenoic acid; DPA, 
Docosapentaenoic acid (n-6 and n-3); ALA, α-linolenic acid; EPA, Eicosapentaenoic acid; 
DHA, docosahexaenoic acid. 
 n-3 balanced n-3 deficient  Statistical effects 
Fatty acids Saline LPS Saline LPS LPS Diet LPS x 
Diet 
SFA 31.5±1.03 30.8±0.87 32.9±1.05 29.6±2.01 <0.05 NS NS 
MUFA 33.9±1.14 37.6±2.69 35.1±1.90 36.0±3.88 NS NS NS 
PUFA 34.3±1.12 31.2±1.85 31.7±2.89 34.0±2.19 NS NS <0.05 
        
18:2 n-6 (LA) 10.2±0.61 8.7±0.98 9.4±1.39 9.8±0.82 NS NS NS 
18:3 n-6 (GLA) 0.20±0.05
a 0.12±0.01b 0.17±0.03a 0.21±0.02a <0.01 NS NS 
20:2 n-6 (EDA) 0.12±0.01 0.14±0.01 0.13±0.08 0.16±0.01 NS NS NS 
20:3 n-6 (DGLA) 1.63±0.21 1.78±0.06 1.65±0.2 1.99±0.06 <0.01 NS NS 
20:4 n-6 (AA) 11.2±0.47 10.8±0.42 14.5±1.18 15.5±1.55 NS <0.001 NS 
22:4 n-6 (DTA) 0.2±0.01 0.2±0.02 0.4±0.04 0.4±0.06 NS <0.001 NS 
22:5 n-6 (DPA) 0.2±0.01 0.34±0.06 3.5±0.03 3.6±0.58 NS <0.001 NS 
Total n-6 23.8±0.84 22.1±1.32 29.8±3.04 31.8±2.23 NS <0.001 NS 
        
18:3 n-3 (ALA) 0.46±0.05
b 0.3±0.08c 0.03±0.01a 0.03±0.01a <0.05 <0.001 <0.05 
20:5 n-3 (EPA) 0.63±0.08
b 0.43±0.1c 0.03±0.01a 0.03±0.01a <0.05 <0.001 <0.05 
22:5 n-3 (DPA) 0.38±0.04
b 0.28±0.06c 0.04±0.01a 0.05±0.01a <0.05 <0.001 <0.05 
22:6 n-3 (DHA) 8.4±0.35
b 7.0±0.51c 0.9±0.11a 1.0±0.22a <0.01 <0.001 <0.01 
Total n-3 9.8±0.44
b 8.0±0.73c 1.1±0.12a 1.1±0.21a <0.01 <0.001 <0.01 
    
 
   
n-6/n-3 2.4±0.09 2.8±0.09 28.7±3.94 28.4±3.10 NS <0.001 NS 
        
        
  
Highlights  
- Maternal omega-3 deficiency has deleterious effects on pups’ brain development  
- Maternal omega-3 deficiency alters fatty acid composition of the fetal and adult offspring 
brain  
- Maternal omega-3 deficiency exacerbates maternal and fetal inflammation  
- Maternal omega-3 deficiency induces spatial memory deficits in the adult offspring  
- There is a strong negative correlation between brain content in omega-3 and cytokines 
production  
 
